Cycle of the vasoactive intestinal peptide and its binding site in a human adenocarcinoma cell line (HT 29)
Open Access
- 1 May 1986
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 156 (3) , 631-636
- https://doi.org/10.1111/j.1432-1033.1986.tb09624.x
Abstract
The disappearance of vasoactive-intestinal-peptide (VIP) binding sites at the cell surface of a cultured target cell, originating from a human colonic adenocarcinoma (HT 29 cell line), was studied, after preexposition of the cell to the peptide, as a function of time, VIP concentration and temperature, Maximum effect (60–80% loss of binding capacity) was obtained after a 5–10 min exposure of the cells at 37°C with a VIP concentration of 100 nM. The t1/2 of maximum disappearance was less than 2 min and the concentration of native VIP giving half-maximum decrease in 125I-VIP binding was 6 nM. The affinity of remaining binding sites for VIP was not affected compared to that of control cells (Kd= 0.3 nM). Disappearance of VIP binding sites was specific since, with the same conditions of preincubation, the specific binding of 125I-labeled epidermal growth factor to HT 29 cells was not modified. The phenomenon was reversible and 90% of binding capacity could be restored in less than 60 min by incubating cells in VIP-free medium. Correlatively we showed, by two independent experimental procedures, that 125I-VIP, initially bound to HT 29 cells, was maximally internalized after 10 min of incubation at 37°C. All the data strongly suggest that: (1) internalization of VIP is receptor-mediated; (2) upon exposure to native VIP, VIP receptors are down-regulated or at least sequestered within HT 29 cells.This publication has 31 references indexed in Scilit:
- Internalization of the vasoactive intestinal peptide (VIP) in a human adenocarcinoma cell line (HT29)European Journal of Biochemistry, 1985
- Molecular mechanisms of receptor desensitization using the β-adrenergic receptor-coupled adenylate cyclase system as a modelNature, 1985
- Covalent cross‐linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29)European Journal of Biochemistry, 1985
- In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells.The Journal of Experimental Medicine, 1984
- 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts.The Journal of cell biology, 1976
- The effects of spontaneous obesity on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes.Journal of Clinical Investigation, 1976
- Thyrotropin-releasing hormone regulates the number of its own receptors in the GH3 strain of pituitary cells in cultureBiochemistry, 1975
- Defect in insulin binding to receptors in obese man. Amelioration with calorie restriction.Journal of Clinical Investigation, 1975
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific ActivityNature, 1962